CML Leukemia and Lymphoma

» Advanced search

Paper of the Month - 2009

• View Archive »

  • ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma. - May, 2012
    Second cancer risk after chemotherapy for Hodgkin’s lymphoma: a collaborative British cohort study. - April, 2012
    Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the Phase 3 randomised ENESTnd trial. - March, 2012
    [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin’s lymphoma. - February, 2012
    Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. - January, 2012
    Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA - December, 2011
    The prognostic significance of IDH2 mutations in AML depends on the location of the mutation - November, 2011
    Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, Phase 2 trial - October, 2011
    Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase. - September, 2011
    Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients - August, 2011
    Predictive factors for outcome and response in patients treated with second-generation tyrosine kinase inhibitors for chronic myeloid leukemia in chronic phase after imatinib failure - July, 2011
    Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia - June, 2011
    Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions - May, 2011
    Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug. - April, 2011
    A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. - March, 2011
    Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized Phase III trial GOELAMS-LTP95. - February, 2011
    High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a Phase 3, randomised, non-inferiority trial. - January, 2011
    Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia. - December, 2010
    In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia. - November, 2010
    Bortezomib induces apoptosis in primitive chronic myeloid leukemia cells including LTC-IC and NOD/SCID repopulating cells. - October, 2010
    Treatment of favorable, limited-stage Hodgkin’s lymphoma with chemotherapy without consolidation by radiation therapy - September, 2010
    Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma - August, 2010
    Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma - July, 2010
    Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era - June, 2010
    Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma - May, 2010
    Results of a Phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma. - April, 2010
    Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin’s lymphoma - March, 2010
    TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia - February, 2010
    First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia - January, 2010
    Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy - 2009
    Autologous stem-cell transplantation in patients with HIV-related lymphoma - 2009
    Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience - 2009
    Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry - 2009
    B-cell clones as early markers for chronic lymphocytic leukemia. - 2009
    Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. - 2009
    Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study. - 2009
    Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB96 international study. - 2009
    Longitudinal changes in Obesity and Body Mass Index Among adult survivors of Childhood Lymphoblastic Leukemia: a report from the childhood cancer survivor study. - 2009
    Childhood leukemia in relation to radio frequency electromagnetic fields in the vicinity of TV and radio broadcast transmitters. - 2009
    Phase III study of R-CVP compared with cyclosphosphamide, vincristine, and prednisone alone in patients with previously and treated advanced follicular lymphoma. - 2009